Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Scopolamine effects on visual information processing, attention and event-related potential map latencies.Psychophysiology. 1992; 29: 315-336
- Human information-processing: Some effects of methylphenidate, age, and scopolamine.Biol Psychiatry. 1984; 19: 649-662
- Effects of oral scopolamine on human stimulus evaluation.Psychopharmacology. 1985; 85: 133-138
- Brain neurotransmitters in aging and dementia: Similar changes across diagnostic dementia groups.Gerontology. 1987; 33: 159-167
- Effects of cotinine on information processing (abstract).Psychophysiology. 1991; 28: S29
- Event-related potentials in human immunodeficiency virus infection.Arch Neurol. 1992; 49: 396-400
- P3 as an index of visual information processing.Current Trends in Event-Related Potential Research (EEG suppl 40). 1987; : 235-240
- Signs of cognitive change in HIV disease: An event-related brain potential study.Neurology. 1991; 41: 209-215
- Simple and choice reaction time in patients with human immunodeficiency virus infection.Ann Neurol. 1989; 25: 460-467
- The effects of mild diastolic hypertension on the results of tests of cognitive function in adults 22 to 59 years of age.J Gen Intern Med. 1992; 7: 19-25
- Does dopamine mediate response processing?.Psychophysiology. 1991; 28 (abstract): S63
☆Portions of this paper were presented as an abstract at the 32nd Annual Meeting of the Society for Psychophysiological Research, San Diego, CA, October 14–18, 1992.
☆☆This work was supported by a grant from the AIDS Clinical Research Center at the University of California San Francisco to Dr. E. Callaway. Normative data was supported by grants from the National Institute of Mental Health (Grants MH22149 and MH38680) and VA Merit review grant to E. Callaway, Tobacco Related Disease Research Program to Dr. R. Halliday, and a gift from the R.J. Reynolds Tobacco Company to E. Callaway. Subject recruitment, neurological evaluation, and neuropsychological and immunological testing were supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (Grant RO1 AA08968) to Dr. G. Fein. We are indebted to Dr. Roy Halliday for his statistical expertise and comments on early versions of this text, and Dr. George Fein for his cooperation on this project and comments on early versions of this text.